• Our Vision

    Better Testing. Better Treatment.
1
/
3
/

Who we are

Diaceutics is the diagnostic development and commercialization service provider.

What we do

We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network.

What we stand for

Our ultimate goal is to drive better testing to enable better treatment decisions for patients.

Who we work with

source-bioscience
promega
merck
bluebirdbio
neo-genomics
roche
boehringer-ingelheim
lilly
takeda
bill-and-melinda-gates-foundation
pfizer
novartis
synlab
astellas
lexicon
celgene
daiichi-sankyo
abbvie
ganymed
immunogen
incyte
bristol-myers-squibb
janssen
amgen
gsk
bayer
gilead

Our Vision

Partnering with stakeholders in healthcare globally to empower patients to receive better treatments through better testing.

Facebook
Twitter
YouTube
LinkedIn